Natco Pharma gets EIR from USFDA for Kothur facility

The receipt of EIR from the United States Food and Drug Administration (USFDA) indicates the successful closure of inspection of the company#39;s drug formulations facility in Kothur, Natco Pharma said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2YKWSdz